Annual Drug Patent Expirations for RADICAVA+ORS
Radicava Ors is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has twelve patent family members in twelve countries.
The generic ingredient in RADICAVA ORS is edaravone. One supplier is listed for this compound. Additional details are available on the edaravone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com